Delivery Order SPE2DB24D2105-SPE2DB24FAPAK
Award Date 4/9/24
Potential Completion Date 4/10/24
Potential Value $21K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $2,419.60 firm fixed price delivery order is for the supply of 4563747408 - Chloroquine Ph 500 mg Tablet 25s, a pharmaceutical product, with a completion date of February 26, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division for the delivery of chloroquine phosphate 500 mg tablets. The $27,583.44 firm fixed price delivery order contract has a completion date of June 3, 2024. Amerisourcebergen, a major pharmaceutical distribution company, has an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31,...
- Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide $23,017.68 worth of chloroquine phosphate. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through...
- This federal contract award, identified as SPE2DX15D2101|SPE2DX24F50RH, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, as a prime contractor. The $4,487.75 firm fixed price delivery order is for the supply of 4563955505 CHLOROQUINE PH 500 MG TABLET 25S to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 500 tablets of Hydroxychloroquine 200 mg, with a contract value of $2,780.34 and a firm fixed price structure. This non-competitive delivery order, issued on December 12, 2025, is due for completion by December 15, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement from the company's existing Indefinite Delivery...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is to provide 4,563,841,489 units of chloroquine phosphate 500 mg tablets in 25-count packages, with a potential value of $2,249.76 and a period of performance through March 5, 2024. This order is not designated as a...
- Amerisourcebergen Drug Corporation, operating as a division of Amerisourcebergen Corporation, has been awarded a $16,068.84 firm fixed price delivery order contract by the Defense Logistics Agency Troop Support Medical to provide 25,500 milligram tablets of chloroquine phosphate. Performance will take place in Conshohocken, Pennsylvania over one day in late July 2023. The Defense Logistics Agency Troop Support Medical supports the medical readiness of the U.S. Armed Forces through its Prime...
- <p>The Defense Logistics Agency issued a $2,342.91 delivery order to Amerisourcebergen Drug Corp on March 5, 2026, for Plaquemin 200 mg tablets (100-count units), with ultimate completion on March 6, 2026.</p> <p>The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999 through December 2026. Place of performance is Conshohocken, PA. Pricing is firm fixed price with no set-aside applied.</p>
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $37,001.51 award is for the delivery of CHLOROQUINE PH 500 MG TABLET 25S, with a completion date of January 9, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, is a prime contractor that provides pharmaceutical products and services to U.S. government agencies, primarily the...
- This federal contract award, valued at $99,734.73, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of...
- SPE2DB24D2105Indefinite Delivery Contract
- SPE2DB24D2105-SPE2DB24FAPAKDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $20,519.19 firm-fixed-price delivery order is for the supply of Plaquenil 200 mg tablets to DLA Troop Support Medical, which provides pharmaceuticals and medical supplies to military treatment programs and facilities. Amerisourcebergen Drug Corp also holds a separate indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 2025, that serves as the primary vehicle for the company to deliver a range of medications and healthcare materials to support the Department of Defense. This contract award does not have a set-aside designation.
Generated 7/9/24, 1:43 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.5k | 4/9/24 |